Pediatric psychopharmacology in primary care: a conceptual framework.
Adolesc Med State Art Rev. 2013 Aug;24(2):371-90, vii
Authors: Riddle MA, dosReis S, Reeves GM, Wissow LS, Pruitt DB, Foy JM
Abstract
In a 2009 policy statement focused on children’s mental health, the American Academy of Pediatrics recommended that pediatric primary care physicians achieve competence in initiating care for children with attention-deficit/hyperactivity disorder (ADHD), anxiety, depression, and substance use/abuse. Because treatment for 3 of these conditions–ADHD, anxiety, and depression–may, under certain conditions, include medication, the primary purpose of this article is to offer guidance to assist primary care physicians in decision-making about their use of psychotropic medications for these conditions. A few medications with proven efficacy and safety are emphasized. Secondarily, other medications that may be useful for other disorders are noted.
PMID: 24298753 [PubMed – in process]
via http://www.ncbi.nlm.nih.gov/pubmed/24298753?dopt=Abstract
